Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
421.53
-1.10 (-0.26%)
Oct 24, 2025, 4:00 PM EDT - Market closed

Vertex Pharmaceuticals Stock Forecast

Stock Price Forecast

The 23 analysts that cover Vertex Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $491.78, which forecasts a 16.67% increase in the stock price over the next year. The lowest target is $405 and the highest is $575.

Price Target: $491.78 (+16.67%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$405$491.78$480$575
Change-3.92%+16.67%+13.87%+36.41%

Analyst Ratings

The average analyst rating for Vertex Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy1098888
Buy666688
Hold11111110910
Sell000000
Strong Sell000000
Total272625242526

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$439$438
HoldMaintains$439$438+3.91%Oct 10, 2025
JP Morgan
JP Morgan
Buy
Maintains
$517$530
BuyMaintains$517$530+25.73%Oct 8, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$550$575
Strong BuyMaintains$550$575+36.41%Oct 2, 2025
Leerink Partners
Leerink Partners
Buy
Upgrades
$458$456
BuyUpgrades$458$456+8.18%Sep 25, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$510$475
BuyMaintains$510$475+12.68%Sep 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
12.23B
from 11.02B
Increased by 10.93%
Revenue Next Year
13.39B
from 12.23B
Increased by 9.55%
EPS This Year
18.38
from -2.08
EPS Next Year
20.63
from 18.38
Increased by 12.24%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.21B7.57B8.93B9.87B11.02B12.23B13.39B
Revenue Growth
49.08%22.06%17.91%10.51%11.66%10.93%9.55%
EPS
10.299.0112.8213.89-2.0818.3820.63
EPS Growth
128.16%-12.44%42.29%8.35%--12.24%
Forward PE
-----22.9320.43
No. Analysts
-----3533
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High12.7B15.1B
Avg12.2B13.4B
Low11.6B11.7B

Revenue Growth

Revenue Growth20252026202720282029
High
15.6%
23.3%
Avg
10.9%
9.6%
Low
5.3%
-4.3%

EPS Forecast

EPS20252026202720282029
High19.7726.88
Avg18.3820.63
Low16.6317.61

EPS Growth

EPS Growth20252026202720282029
High-
46.2%
Avg-
12.2%
Low-
-4.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.